VR Logo

Syngene International Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

49 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 download pdf full AR download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2020 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2019 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2018 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2017 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2016 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2015 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: Kiran Mazumdar Shaw

Managing Director: Jonathan Hunt

Group: --

Listing: NSE: SYNGENE, BSE: 539268

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: R 23,893.48 Cr

Revenue (TTM): R 2,447.80 Cr

Earnings (TTM): R 406.80 Cr

Cash: R 1,065.90 Cr

Total Debt: R 772.30 Cr

Promoters' ownership: 70.42%

Liquidity: High

52 Week range: R 490.50 - 700.00

Face value: R10.00

Shares outstanding: 40,07,96,500

10 Years Aggregate:

  • CFO: 3,719.00 Cr
  • EBITDA: 3,745.30 Cr
  • Net Profit: 2,461.30 Cr

Stock Performance

Time Period Syngene International S&P BSE Healthcare S&P BSE Mid Cap
YTD-8.1817.5037.20
1 month8.601.76-2.62
3 months-4.93-1.525.85
1 Year1.6125.2245.23
3 Years29.3721.8318.05
5 Years15.3810.1814.75
10 Years--15.4615.81
As on 29-Nov-2021
Year Syngene International S&P BSE Mid Cap S&P BSE Healthcare
202098.4519.8761.45
201914.86-3.05-3.55
20183.46-13.31-5.89
2017-3.6548.130.49
201634.517.97-12.88

Review & Analysis